leisure time -WSS

leisure time

author：entertainment 2025-10-02 00:40:38 - browse：55

To much of the public, the promise of telehealth is all about convenience — get the prescription you need quickly, and get it delivered right to your door. But as digital health companies build out their weight loss businesses, capitalizing on the popularity of drugs like Wegovy and Ozempic, they’re courting a very different audience: payers and employers who have a vested interest in preventing quick scripts.

Payers are reeling as they try to figure out how to sustainably cover GLP-1 receptor agonists, a class of remarkably effective but expensive obesity and type 2 diabetes drugs. So in the last six months, digital health companies including Teladoc, Found, Hello Alpha, and Calibrate have advanced enterprise products that pair virtual visits and prescriptions with lifestyle coaching. Their hope is that more and more payers and employers will offer their programs as a way to support lasting weight loss and metabolic health — or even require them if patients want their drugs reimbursed.

The competition is growing quickly. Telehealth companies once focused exclusively on consumers are now marketing to payers. Enterprise programs for chronic care management are promoting new services to support patients on obesity drugs. And companies like Noom and WeightWatchers, which have built gargantuan weight loss businesses for consumers and businesses alike, are starting to prescribe the drugs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： In new study, freeze

focus

WSS

Criminal prosecution for violating HIPAA: an emerging threat

Helping hospitals and community health centers plan for resilience

Caitlin Bernard's story shows physicians can't shy from advocacy

HIPAA doesn't protect reproductive records from prosecutors

Solving academic medical centers' existential crisis

Caitlin Bernard's story shows physicians can't shy from advocacy

focus

leisure time

focus

Continuity nursing helped my family in our darkest PICU moments

Cytokinetics CEO stresses company can launch heart drug on its own

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Addiction experts warn against a second 'war on drugs'

Medical leaders decry Supreme Court decision on affirmative action

HIV vaccine remains elusive. Immunologists keep trying new ideas

Jerome Adams on the need for new antivirals for Covid

Russian special forces kill a gunman who broke into a private house near Moscow

Medicare details structure of new drug price negotiation program

It's time to retire 'poor historian' from clinicians' vocabularies

explore

How artificial intelligence is being used to detect, treat cancer

With measles on the rise, a personal story of a devastating disease

Venture capitalist Bob Kocher on the state of digital health

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

Data integrity in scientific journals requires "effort" by publishers, institutions

Case highlights the risks of experimental stem cell therapy

hotspot

focus

focus

hotspot